Fears that President Trump will push through policies that will damage healthcare and science are generating active resistance from the scientific community in the US and beyond.
Pharma CEOs including Novartis’ Joe Jimenez are to meet Donald Trump this afternoon – following a turbulent start to his presidency and his attacks on the industry over pricing.
